TY - JOUR T1 - Use of Hybrid Capillary Tube Apparatus on 400 MHz NMR for Quantitation of Crucial Low-Quantity Metabolites Using aSICCO Signal JF - Drug Metabolism and Disposition JO - Drug Metab Dispos SP - 1215 LP - 1224 DO - 10.1124/dmd.117.077073 VL - 45 IS - 12 AU - Ranjeet Tiwari AU - Deepak Ahire AU - Hemantha Kumar AU - Sarmistha Sinha AU - Siddheshwar Kisan Chauthe AU - Murali Subramanian AU - Ramaswamy Iyer AU - Ramakanth Sarabu AU - Lakshmikant Bajpai Y1 - 2017/12/01 UR - http://dmd.aspetjournals.org/content/45/12/1215.abstract N2 - Metabolites of new chemical entities can influence safety and efficacy of a molecule and often times need to be quantified in preclinical studies. However, synthetic standards of metabolites are very rarely available in early discovery. Alternate approaches such as biosynthesis need to be explored to generate these metabolites. Assessing the quantity and purity of these small amounts of metabolites with a nondestructive analytical procedure becomes crucial. Quantitative NMR becomes the method of choice for these samples. Recent advances in high-field NMR (>500 MHz) with the use of cryoprobe technology have helped to improve sensitivity for analysis of small microgram quantity of such samples. However, this type of NMR instrumentation is not routinely available in all laboratories. To analyze microgram quantities of metabolites on a routine basis with lower-resolution 400 MHz NMR instrument fitted with a broad band fluorine observe room temperature probe, a novel hybrid capillary tube setup was developed. To quantitate the metabolite in the sample, an artificial signal insertion for calculation of concentration observed (aSICCO) method that introduces an internally calibrated mathematical signal was used after acquiring the NMR spectrum. The linearity of aSICCO signal was established using ibuprofen as a model analyte. The limit of quantification of this procedure was 0.8 mM with 10 K scans that could be improved further with the increase in the number of scans. This procedure was used to quantify three metabolites—phenytoin from fosphenytoin, dextrophan from dextromethorphan, and 4-OH-diclofenac from diclofenac—and is suitable for minibiosynthesis of metabolites from in vitro systems. ER -